Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of ageing.
Shift Bioscience has raised €15M across 1 funding round from 1 investor, most recently a Seed round in Oct 2024. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-10-15 | Seed | €15M |
| Business Growth Fund (BGF) |
| View deal → |
